Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Carbimazole And Autoantibody Synthesis In Hashimoto's Thyroiditis

Alan M. McGregor, H. Kaye Ibbertson, Bernard Rees Smith and Reginald Hall
The British Medical Journal
Vol. 281, No. 6246 (Oct. 11, 1980), pp. 968-969
Published by: BMJ
Stable URL: http://www.jstor.org/stable/25441646
Page Count: 2
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Preview not available

Abstract

Serum thyroxine, thyrotrophin, and thyroid microsomal antibody levels were measured in 20 patients with Hashimoto's thyroiditis and hypothyroidism before, during, and after treatment with carbimazole or placebo. Thyroid microsomal antibody levels fell during treatment in the 10 patients who received carbimazole, while serum thyroxine and thyrotrophin levels did not change. There were no changes in the placebo group. The study proves support for the concept that carbimazole may act directly on autoantibody synthesising lymphocytes localised in the thyroid. Such an effect might be valuable in influencing the autoimmune process in autoimmune thyroid disease.

Page Thumbnails

  • Thumbnail: Page 
968
    968
  • Thumbnail: Page 
969
    969